|Home Page : www.otcjournal.com
Email Questions or Comments To: email@example.com
OTC Journal Members:
There's been a volume explosion today in yesterday's feature- Liberator (LUVU). The stock made a new all time high of $.45, and has already traded nearly 400,000 shares today- the highest volume in its history.
In my view, this stock is now poised to go to $.75. If you missed the gigantic move in Luxeyard (LUXR)- now $1.70 - up from the $.80 level of my first feature less than one month ago, don't miss LUVU.
Technically, this one looks poised for a really big run.
A reminder: Catch me live on TV every Monday from 12 to 2PM eastern.
The OTC Journal Newsletter is an electronic publication committed to providing our readers with useful information on publicly traded companies. The Newsletter contracts with publicly traded companies and receives compensation from them or third parties as payment for publishing information and opinions about the company and the trading market for their securities. Principals of the Newsletter may also purchase or sell securities of the companies in the open market from time to time. The positions, if any, that the Newsletter or its principals presently maintain in the securities of the companies are disclosed here (click here) and should be considered in making an investment decision regarding these companies securities. The Newsletter and its principals reserve the right to acquire additional shares or liquidate some or all of the positions they may hold in the issuer’s securities at any time in the future without further notice. These publications should not be considered to be independent publications concerning the company.
All statements and opinions expressed herein are those of the editors and are subject to change without notice. The Newsletter maintains editorial control over its publications and the companies profiled therein do not have any editorial rights concerning the information published about them. While we believe all sources of information provided by us and contained in our publication to be accurate and reliable, we cannot and do not guarantee the accuracy of information we received from third parties.
The information found in this profile is protected by the copyright laws of the United States and may not be copied, or reproduced in any way without the express written consent of the editors of otcjournal.com.